Mustang Bio Inc (NAS:MBIO)
$ 0.2 -0.0102 (-4.82%) Market Cap: 2.50 Mil Enterprise Value: 3.56 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 31/100

Mustang Bio Inc at B Riley Securities Oncology Conference (Virtual) Transcript

Jan 18, 2023 / 08:00PM GMT
Release Date Price: $9.24 (-11.11%)
Mayank Mamtani
B. Riley Securities, Inc. - Analyst

Hi, good afternoon for folks on the East Coast and also on the West Coast. So we'll get started with our next company, Mustang Bio, where we have with us President, CEO, Manny Litchman. Thanks to Manny and the audience here for being part of the B. Riley Oncology Conference.

This is Mayank Mamtani, one of the senior biotech analysts on the Healthcare Research team. At any point during the fireside chat, feel free to e-mail me direct questions at [email protected].

Manny, great to have you here with us today. Maybe at the outset, we can hear from you the Mustang Bio story and some of the pipeline programs that you're advancing specifically based on cell therapy platform and development capabilities that you think are differentiated.

Manny, the floor is all yours.

Manny Litchman
Mustang Bio, Inc. - President, CEO and Director

Yeah. Thanks so much, Mayank. And thanks so much for the opportunity to answer questions today at the fireside chat. To kick things off, let me say that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot